If these medications improve memory or cerebral blood flow safely, the implications reach beyond clinical trials. Safer, widely available therapies could slow the slide toward disability for millions and reshape how doctors screen and treat people at risk. The work also raises questions about who will benefit most and how treatments could be matched to individual biology, lifestyle, and access to care.
There is real hope here and clear reasons to stay curious. Learn how these findings connect to brain metabolism, vascular health, and the broader goal of supporting human potential as we age. Follow the study to see which patients respond, how long benefits last, and what this could mean for making aging more inclusive and resilient.
Two widely available diabetes medications appear to safely improve brain health among people with early brain decline. The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health and blood flow to the brain,…